1α,25-Dihydroxyvitamin D3; its role for homeostasis of keratinocytes

Journal of Nutritional Biochemistry

Volumn 7, Issue 12, 1996, Pages 642-649

  Wu, Shuling ^a   Geilen, Christoph C ^a   Tebbe, Beate ^a   Orfanos, Constantin E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

apoptosis; keratinocyte; signal transduction; terminal differentiation; vitamin D3

Indexed keywords

CALCIPOTRIOL; CALCITRIOL;

APOPTOSIS; DIFFERENTIATION; HOMEOSTASIS; HUMAN; HUMAN CELL; KERATINOCYTE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030463918     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(96)00125-8     Document Type: Review

References (85)

1. 3 receptor in human skin biopsies. J. Clin. Endocrinol. Metab. 51, 1463-1465
2. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206, 1188-1190
3. 3. J. Clin. Endocrinol. Metabol. 56, 824-830
4. 3 receptors in normal and psoriatic skin. J. Invest. Dermatol. 97, 230-236
5. 5 Bikle, D.D. and Pillai, S. (1993). Vitamin D, calcium and epidermal differentiation. Endocrine. 14, 3-19
6. 3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocyte. Differentiation 47, 173-188
7. 3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes. J. Invest. Dermatol. 103, 323-329
8. 8 Okuda, K.-I., Usui, E., and Ohyama, Y. (1995). Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism. J. Lipid Res. 36, 1641-1652
9. 3-dependent rapid and estrogen-dependent slow recognition of vitamin D receptor. J. Cell Biol. 111, 2385-2395
10. ++ and phospholipids in isolated rat liver nuclei. FEBS Lett. 259, 205-208
11. 11 Barrack, E.R. (1987). Steroid hormone receptor localization in the nuclear matrix: interaction with acceptor site. J. Steroid Biochem. 27, 115-121
12. 3-modulated heterodimer. J. Biol. Chem. 266, 23296-23305
13. 3 mediated transcriptional activation. Mol. Endocrinol. 5, 373-385
14. 3 increases intracellular calcium in human keratinocytes. Brit. J. Dermatol. 124, 230-235
15. 15 Jones, K.T. and Sharpe, G.R. (1994). Intracellular free calcium and growth changes in single human keratinocytes in response to vitamin D and five 20-epi-analogues. Arch. Dermatol. Res. 286, 123-129
16. 3 increases calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J. Nutr. Biochem. 1, 81-87
17. 3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem. 264, 19076-19080
18. 3-induced HL-60 cell differentiation. J. Biol. Chem. 265, 15823-15831
19. 19 Hannun, Y.A. (1994). The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269, 3125-3128
20. 20 Obeid, L.M. and Hannun, Y.A. (1995). Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. Cell Biochem. 58, 191-198
21. 21 Obeid, L.M., Linardic, C.M., Karolak, L.A., and Hannun, Y.A. (1993). Programmed cell death induced by ceramide. Science 259, 1769-1771
22. 22 Jarvis, W.D., Kolesnick, R.N., Fomari, F.A., Traylor, R.S., Gerwitz, D.A., and Grant, S. (1994). Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91, 73-77
23. 23 Bielawska, A., Linadic, C.M., and Hannun, Y.A. (1992). Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs. J. Biol. Chem. 267, 18493-18497
24. 24 Geilen, C.C., Bektas, M., Wieder, T.H., and Orfanos, C.E. (1996). The vitamin D3 analogue, calcipotriol activates sphingomyelin hydrolysis in human keratinocytes. FEBS Lett. 378, 88-92
25. ++-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis 9, 1033-1038
26. 26 Sharpe, G.R., Gillespie, J.I., and Greenwell, J.R. (1989). An increase in intracellular free calcium is an early event during differentiation of cultured human keratinocytes. FEBS Lett. 254, 25-28
27. 27 Haake, A.R. and Polakowska, R.R. (1993). Cell death by apoptosis in epidermal biology. J. Invest. Dermatol. 93, 107-112
28. 28 Schwartzman, R.A., and Cidlowski, J.A. (1993). Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine. 14, 133-151
29. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions. J. Invest. Dermatol. 86, 709-714
30. 30 Lichti, U. and Yuspa, S.H. (1988). Modulation of tissue and epidermal transglutaminases in epidermal cells after treatment with 12-O-tetradecanoyphorbol-13-acetate and/or retinoic acid in vivo and in culture. Cancer Res. 48, 74-81
31. 31 Dlugosz, A.A. and Yuspa, S.H. (1994). Protein kinase C regulates keratinocyte transglutaminase (TGk) gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiation by calcium. J. Invest. Dermatol. 102, 409-414
32. 32 Lee, E. and Yuspa, S.H. (1991). Changes in inositol phosphate metabolism are associated with terminal differentiation and neoplasia in mouse keratinocytes. Carcinogenesis 12, 1651-1658
33. 1b- and calcium-stimulated human keratinocytes. Biochem. Biophys. Res. Commun. 190, 688-694
34. 34 Schroeder, W.T., Thacher, S.M., Stewart-Galetka, S., Annarella, M., Chema, D., Siciliano, M.J., Davies, P.J.A., Tang, H.Y., and Sowa, B.A. (1992). Type keratinocyte transglutaminase: expression in human skin and psoriasis. J. Invest. Dermatol. 99, 27-34
35. 35 Esmann, J., Voorhees, J.J., and Fisher, G.J. (1989). Increased membrane-associated transglutaminase activity in psoriasis. Biochem. Biophys. Res. Commun. 164, 219-224
36. 36 Ewen, M.E., Sluss, H.K., Whitehouse, L.L., and Livingston, D.M. (1993). TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020
37. 37 Koff, A., Ohtsuki, M., Polyak, K., Roberts, J.M., and Massague, J. (1993). Negative regulation G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536-539
38. 38 Munger, K., Pietenpol, J.A., Pittelkow, M.R., Holt, J.T., and Moses, H.L. (1992). Transforming growth factor β1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Different. 3, 291-298
39. 3 is linked to dephosphorylation of retinoblastoma gene product. Biochem. Biophys. Res. Commun. 196, 487-493
40. 40 Kobayashi, T., Hashimoto, K., and Yoshikawa, K. (1995). Growth inhibition of human keratinocytes by MC903 (calcipotriol) is linked to dephosphorylation of retinoblastoma gene product. JEADV. 5, 132-138
41. 41 McCall, C.A. and Cohen, J.J. (1991). Programmed death in terminally differentiating keratinocytes: role of endogenous endonuclease. J. Invest. Dermatol. 97, 111-114
42. 3. J. Invest. Dermatol. 98, 42S-49S
43. 43 Pillai, S., Bikle, D.D., and Elias, P.M. (1988). 1α,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J. Biol. Chem. 263, 5390-5395
44. 3. Arch. Dermatol. 123, 1677-1682
45. 45 Ebner, H. and Gebhart, W. (1975). Light and electron microscopic differentiation of amyloid and colloid or hyaline bodies. Br. J. Dermatol. 92, 637-645
46. 46 Danno, K. and Horio, T. (1981). Sulfhydryl and disulfide stainings of subepidermal hyaline bodies. Br. J. Dermatol. 104, 437-442
47. 47 Gomes, M.A., Staquet, M.J., and Thivolet, J. (1981). Staining of colloid bodies by keratin antisera in lichen planus. Am. J. Dermatopathol. 3, 341-347
48. 48 Eto, H., Hashimoto, K., Kobayashi, H., Fukaya, T., Matsumoto, M., and Sun, T.T. (1984). Differential staining of cytoid bodies and skin-limited amyloid with monoclonal anti-keratin antibodies. Am. J. Pathol. 116, 473-481
49. 49 Hashimoto, K. (1976). Apoptosis in lichen planus and several other dermatoses. Intra-epidermal cell death with filamentous degeneration. Acta Dermatol. Venereol. 56, 187-210
50. 50 Kanerva, L. (1990). Electron microscopic observations of dyskeratosis, apoptosis, colloid bodies and fibrillar degeneration after skin irritation with dithranol. J. Cutan. Pathol. 17, 37-44
51. 51 Budtz, P.E. and Spies, I. (1989). Epidermal tissue homeostasis: apoptosis and cell emigration as mechanisms of controlled cell deletion in the epidermis of the toad, bufo bufo. Cell Tissue Res. 256, 475-486
52. 52 Danno, K. and Horio, T. (1982). Formation of UV-induced apoptosis relates to the cell cycle. Br. J. Dermatol. 107, 423-428
53. 53 Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257
54. 54 Grubauer, G., Romani, N., Kofler, H., Stanzl, U., Fritsch, P., and Hintner, H. (1986). Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies. J. Invest. Dermatol. 87, 466-471
55. 3 receptors. Cell 65, 1255-1266
56. 56 Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, L.J., Grippo, J.F., and Hunziker, W. (1993). Two nuclear signaling pathways for vitamin D. Nature 361, 657-660
57. 57 Lee, S.W., Morhenn, V.B., Ilnicka, M., Engi, E.M., and Allison, A.C. (1991). Autocrine stimulation of interleukin-1 and transforming growth factor production in human keratinocytes and its antagonism by glucocorticoids. J. Invest. Dermatol. 97, 106-110
58. 58 Krueger, J.G., Krane, J.F., Carter, M., and Gottlieb, A.B. (1990). Role of growth factors, cytokines and their receptors in the pathogenesis of psoriasis. J. Invest. Dermatol. 94, 135S-140S
59. 58a Oxholm, A., Oxholm, P., Staberg, B., and Bendtzen, K. (1989). Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903). Acta. Dermatol. Venereol. (Stockh) 69, 385-390
60. 59 Gillitzer, R., Berger, R., Mielke, V., Müller, C., Wolff, K., and Stingl, G. (1991). Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J. Invest. Dermatol. 97, 73-79
61. 60 Schröder, J.M., Gregory, H., Young, I., and Christophers, E. (1992). Neutrophil activating proteins in psoriasis. J. Invest. Dermatol. 98, 241-247
62. 61 Nickoloff, B.J. (1988). Keratinocytes produce a lymphocyte inhibitory factor which is partially reversible by an antibody to transforming growth factor-β. Ann. N.Y. Acad. Sci. 548, 312-320
63. 62 George, M.D., Vollberg, T.M., Floyd, E., Stein, J.P., and Jetten, A.M. (1991). Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J. Biol. Chem. 265, 11098-11104
64. 3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes. J. Invest. Dermatol. 93, 706-712
65. 3 on human keratinocytes cultured in serum-free medium. Biochem. Biophys. Res. Commun. 166, 916-923
66. 65 Ginsberg, D., Mechta, F., Yaniv, M., and Oren, M. (1991). Wild type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88, 9979-9983
67. 66 Lu, Q., Pousom, R., Wong, L., and Hanby, A.M. (1993). Bcl-2 expression in adult and embryonic non-haematopoietic tissue. J. Pathol. 169, 431-437
68. 67 Bianchi, L., Farrace, M.G., Nini, G., and Piacentini, M. (1994). Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin. J. Invest. Dermatol. 103, 829-833
69. 68 Bursch, W., Oberhammer, F., and Schulte-Hermann, R. (1992). Cell death by apoptosis and its protective role against disease. Trends. Pharmacol. Sci. 13, 245-251
70. 3 protects HL-60 cells against apoptosis but down-regulates the expression of bcl-2 gene. Exp. Cell. Res. 209, 367-374
71. 70 Zhong, L.T., Sarafian, T., Kane, D.J., Charles, A.C., Man, S.P., Edwards, R.H., and Bredesen, D.E. (1993). Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90, 4533-4537
72. 71 Kragballe, K. and Fogh, K. (1991). Long-term efficacy and tolerabtlity of topical calcipotriol in psoriasis. Acta Dermatol. Venereol. (Stockh) 71, 475-478
73. 72 Kragballe, K., Beck, H.I., and Søgaad, H. (1988). Improvement of psoriasis by a topical vitamin D3 analogue (MC903) in a double-blind study. Br. J. Dermatol. 199, 223-230
74. 73 Prens, E.P., Benne, K., van Damme, J., Bakkus, M., Brakel, K., Benner, R., and van Joost, T. (1990). Interleukin 1 and interleukin 6 in psoriasis. J. Invest. Dermatol. 95, 121S-124S
75. 3. Proc. Natl. Acad. Sci. USA 82, 5409-5412
76. 3 prolongs survival of leukemic mice. Proc. Natl. Acad. Sci. USA 87, 3929-3932
77. 3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J. Dermatol. 17, 97-103
78. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol. 42, 1569-1575
79. 3 on human hair follicle growth and hair fiber production in whole-organ cultures. J. Invest. Dermatol. 103, 318-322
80. 3 receptors during murine hair cycle. Br. J. Dermatol. 131, 477-482
81. 80 Hochberg, Z., Gilhar, A., and Haim, S. (1985). Calcitriol-resistant rickets with alopecia. Arch. Dermatol. 121, 646-647
82. 3 resistant rickets in seven related families. J. Clin. Invest. 86, 2071-2079
83. 82 Holick, M.F. (1985). Vitamin D resistance and alopecia. Arch. Dermatol. 121, 601-603
84. 3 analogues on HL-60 myeloid leukemic cells. Leukocyte Res. 17, 749-757
85. 84 Schrader, M., Bendik, I., Becker-Andre, M., and Carlberg, C. (1993). Interaction between retinoic acid and vitamin D signaling pathways. J. Biol. Chem. 268, 17830-17836